Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM [Phase 3]

View source ↗

Summary

Phase 3 study evaluating XW003 versus dulaglutide in adults with type 2 diabetes mellitus has completed enrollment/status, with results not provided in the snip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• TRULICITY (DULAGLUTIDE)
• XW003

Snippet

Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. | Conditions: T2DM, Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED